Diagnostic laboratory industry performance is shaped by big test providers, expanding testing demand, and fast-moving technology. In 2023, U.S. labs conducted 14.5 billion tests, with 65% performed in hospital settings. Meanwhile, the U.S. diagnostic laboratory testing market reached $85.6 billion and is forecast to grow through 2028, supported by advances across molecular, in vitro, and digital pathology workflows.
Key Takeaways
- Quest Diagnostics held 28% U.S. independent lab market share in 2023.
- LabCorp commanded 32% share of U.S. clinical lab testing volume in 2023.
- Roche Diagnostics global IVD market share was 24% in 2023.
- The global clinical laboratory services market size was valued at USD 243.0 billion in 2022 and is expected to grow at a CAGR of 5.9% from 2023 to 2030, driven by rising chronic disease prevalence.
- U.S. diagnostic laboratory testing market revenue reached $85.6 billion in 2023, with a projected CAGR of 6.2% through 2028 due to increased demand for personalized medicine.
- The molecular diagnostics market was valued at $15.49 billion in 2022 and is projected to reach $27.17 billion by 2030 at a CAGR of 7.3%.
- U.S. diagnostic labs conducted 14.5 billion tests in 2023, with 65% in hospital settings.
- Europe represented 28% of global IVD market share with €28.5B in 2022.
- Asia-Pacific diagnostics market grew 9.2% in 2023, led by China at $12.4B.
- U.S. clinical lab revenue grew 4.2% YoY in 2023 to $92.1 billion.
- Quest Diagnostics reported $9.3 billion in revenue for 2023, up 6.1% from 2022.
- LabCorp (Laboratory Corporation of America) achieved $12.16 billion revenue in 2023, with net earnings of $1.1 billion.
- PCR technology adoption in labs reached 92% globally by 2023.
- Next-generation sequencing (NGS) accounted for 45% of molecular diagnostics volume in 2023.
- AI integration in pathology diagnostics improved accuracy by 25% in clinical trials by 2023.
In 2023, U.S. diagnostics surged with growing test volumes and AI adoption, while major players maintained leading market shares.
Related reading
02 · Category
Market Size & Growth20 stats
01
The global clinical laboratory services market size was valued at USD 243.0 billion in 2022 and is expected to grow at a CAGR of 5.9% from 2023 to 2030, driven by rising chronic disease prevalence.
02
U.S. diagnostic laboratory testing market revenue reached $85.6 billion in 2023, with a projected CAGR of 6.2% through 2028 due to increased demand for personalized medicine.
03
The molecular diagnostics market was valued at $15.49 billion in 2022 and is projected to reach $27.17 billion by 2030 at a CAGR of 7.3%.
04
In vitro diagnostics (IVD) market in Europe stood at €28.5 billion in 2022, expected to expand at 4.8% CAGR to 2028 amid regulatory harmonization.
05
Point-of-care diagnostics market grew to $42.7 billion globally in 2023, with a forecasted CAGR of 10.1% to $92.4 billion by 2032.
06
Asia-Pacific clinical diagnostics market valued at $35.2 billion in 2022, projected CAGR of 8.5% through 2030 due to healthcare infrastructure investments.
07
U.S. pathology services market size was $22.4 billion in 2023, anticipated to grow at 5.7% CAGR to 2030 with advances in digital pathology.
08
Global immuno-diagnostics market reached $28.9 billion in 2022, expected to hit $42.3 billion by 2029 at 5.5% CAGR.
09
Clinical chemistry analyzers market was $12.5 billion in 2023, projected to grow to $18.7 billion by 2031 at 5.2% CAGR.
10
Latin America diagnostics market valued at $8.1 billion in 2022, with 7.2% CAGR forecast to 2028 driven by infectious disease testing.
11
Global lab automation market size hit $5.3 billion in 2023, expected CAGR of 9.8% to $11.2 billion by 2030.
12
Middle East & Africa IVD market was $2.9 billion in 2022, projected 6.4% CAGR through 2030.
13
U.S. genetic testing market grew to $7.8 billion in 2023, with 12.5% CAGR expected to 2032.
14
Companion diagnostics market valued at $6.2 billion in 2022, forecasted to $12.9 billion by 2030 at 9.6% CAGR.
15
Digital pathology market reached $1.1 billion in 2023, projected 13.2% CAGR to $3.2 billion by 2030.
16
Global hematology analyzers market was $3.9 billion in 2022, expected to grow at 6.1% CAGR to 2030.
17
Microbiology testing market size stood at $5.8 billion in 2023, with 7.8% CAGR forecast to $10.4 billion by 2031.
18
Tissue diagnostics market valued at $4.7 billion in 2022, projected 7.3% CAGR to 2030.
19
Global urinalysis market was $1.4 billion in 2023, expected 5.9% CAGR through 2032.
20
Coagulation testing market reached $3.2 billion in 2022, forecasted 6.5% CAGR to $5.4 billion by 2030.
03 · Category
Regional Distribution18 stats
01
U.S. diagnostic labs conducted 14.5 billion tests in 2023, with 65% in hospital settings.
02
Europe represented 28% of global IVD market share with €28.5B in 2022.
03
Asia-Pacific diagnostics market grew 9.2% in 2023, led by China at $12.4B.
04
U.S. accounted for 42% of global clinical lab services market in 2023.
05
Germany's lab testing volume per capita was 25 tests annually in 2023.
06
India diagnostic market reached $1.5 trillion INR ($18B USD) in FY2023.
07
Brazil's private labs handled 70% of 2.1 billion tests in 2023.
08
Japan molecular diagnostics market share 15% of Asia-Pacific in 2023.
09
UK NHS labs processed 1.2 billion tests in 2023, 40% outsourced.
10
Australia lab services expenditure was AUD 12B in 2023, 5% population growth driver.
11
Middle East diagnostics market penetration 45% urban vs 20% rural in 2023.
12
Canada clinical labs revenue $8.9B CAD in 2023, 55% public funded.
13
South Korea per capita diagnostic spend $120in 2023, highest in Asia.
14
Africa diagnostics market only 1.5% global share despite 18% population.
15
France independent labs market 35% share, €9.2B revenue 2023.
16
China imported 60% of high-end diagnostic equipment in 2023.
17
Mexico lab testing volume 1.8 billion tests, 80% private sector.
18
Russia diagnostics market $4.2B in 2023, 7% import dependency.
Interpretation
Regional Distribution Interpretation
From a regional distribution standpoint, the industry’s center of gravity is clearly shifting toward Asia as Asia-Pacific diagnostics grew 9.2% in 2023 with China leading at $12.4B, while the U.S. still drives a major share of activity with 42% of global clinical lab services in 2023.
More related reading
04 · Category
Revenue & Financials17 stats
01
U.S. clinical lab revenue grew 4.2% YoY in 2023 to $92.1 billion.
02
Quest Diagnostics reported $9.3 billion in revenue for 2023, up 6.1% from 2022.
03
LabCorp (Laboratory Corporation of America) achieved $12.16 billion revenue in 2023, with net earnings of $1.1 billion.
04
Sonic Healthcare's global revenue from laboratory services was AUD 6.2 billion in FY2023, EBITDA margin at 18.4%.
05
Average profit margin for U.S. diagnostic labs was 12.5% in 2023, up from 10.8% in 2022.
06
Bio-Reference Laboratories revenue hit $1.4 billion in 2023, with operating income margin of 15.2%.
07
Eurofins Scientific diagnostics division revenue grew 8.7% to €3.1 billion in 2023.
08
U.S. independent labs average EBITDA margin was 22.3% in 2023 per industry benchmarks.
09
Cerba HealthCare revenue from lab services reached €1.2 billion in 2023, up 11% YoY.
10
Synlab AG reported €2.4 billion revenue in 2023 for clinical diagnostics, with 7.9% growth.
11
Unilabs (Switzerland) lab revenue was CHF 1.1 billion in 2023, EBITDA €185 million.
12
Average R&D spend for top diagnostic firms was 8.2% of revenue in 2023.
13
Quest Diagnostics base lab testing revenue per requisition averaged $45.20in Q4 2023.
14
LabCorp's consolidated net revenues per clinical lab requisition rose 3.4% to $52.10 in 2023.
15
Global diagnostics M&A deal value totaled $15.2 billion in 2023.
16
U.S. hospital-owned labs revenue share was 58% of total $92B market in 2023.
17
Physician office labs generated $18.7 billion in U.S. revenue in 2023.
Interpretation
Revenue & Financials Interpretation
In the Revenue & Financials view, U.S. clinical lab revenue climbed 4.2% year over year to $92.1 billion in 2023 and average profit margins rose to 12.5% from 10.8% the year before, signaling both top line growth and improving profitability across the sector.
05 · Category
Technological Advancements18 stats
01
PCR technology adoption in labs reached 92% globally by 2023.
02
Next-generation sequencing (NGS) accounted for 45% of molecular diagnostics volume in 2023.
03
AI integration in pathology diagnostics improved accuracy by 25% in clinical trials by 2023.
04
Digital pathology slide scanners deployment grew 28% YoY to 15,000 units worldwide in 2023.
05
Point-of-care (POC) nucleic acid testing devices market penetration hit 35% in hospitals by 2023.
06
CRISPR-based diagnostics approved for 12 pathogens in labs by end of 2023.
07
Mass spectrometry adoption in clinical labs rose to 62% for proteomics in 2023.
08
Liquid biopsy tests for cancer grew 40% in utilization, detecting ctDNA with 95% sensitivity.
09
Microfluidics platforms reduced diagnostic turnaround time by 70% to under 1 hour in 2023 pilots.
10
Biosensor-based glucose monitoring accuracy reached 99.2% in lab validations 2023.
11
Cloud-based LIMS (Laboratory Information Management Systems) adoption hit 78% in large labs.
12
Multiplex immunoassay panels for 50+ cytokines standardized in 85% of reference labs by 2023.
13
Robotic automation handled 65% of routine blood processing in top 100 U.S. labs in 2023.
14
Wearable sensor data integration into lab diagnostics workflows increased by 55%.
15
Single-cell sequencing applications in diagnostics grew to 22% of NGS workflows.
16
Blockchain for lab data security implemented in 12% of EU labs by 2023.
17
3D-printed organ-on-chip models validated for drug toxicity testing in 75 labs.
18
Quantum dot-based fluorescent probes improved detection limits to 1 fM in 2023 assays.
Interpretation
Technological Advancements Interpretation
Across technological advancements in 2023, diagnostics is rapidly modernizing with PCR adoption reaching 92% globally and AI in pathology boosting accuracy by 25% in trials, while digital slide scanners grew 28% YoY to 15,000 units and NGS drove 45% of molecular testing volume.
report visual · Comparison
Top players’ U.S. independent lab market share (2023)
LabCorp led U.S. independent clinical lab testing volume share in 2023, with Quest Diagnostics close behind.
LabCorp commanded 32% share of U.S. clinical lab testing volume in 2023.32%
Quest Diagnostics held 28% U.S. independent lab market share in 2023.
28%
Roche Diagnostics global IVD market share was 24% in 2023.
24%
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Henrik Dahl. (2026, February 13). Diagnostic Laboratory Industry Statistics. Gitnux. https://gitnux.org/diagnostic-laboratory-industry-statistics
MLA
Henrik Dahl. "Diagnostic Laboratory Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/diagnostic-laboratory-industry-statistics.
Chicago
Henrik Dahl. 2026. "Diagnostic Laboratory Industry Statistics." Gitnux. https://gitnux.org/diagnostic-laboratory-industry-statistics.
Sources & references
59 datasets cited across this report · attribution is report-level